Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News on Pharma

Mpox outbreak now under control in South Florida

FORT LAUDERDALE, Fla. — The mpox emergency in South Florida is contained, but experts say it is not entirely over.

Tribune News Service

BeiGene Stock Shows Market Leadership With Jump To 82 RS Rating

BeiGene ADR sees its Relative Strength Rating move into the 80-plus level.

Investors Business Daily

The FDA clears updated COVID-19 vaccines for kids under age 5

The decision aims to better protect the littlest kids amid an uptick in COVID-19 cases around the country. The Centers for Disease Control and Prevention is expected to sign off soon.

WEKU

From analysis to the latest developments in health,
read the most diverse news in one place.

Why Mirati Therapeutics Stock Lost Half Its Value In Just Three Days

Mirati Therapeutics' pain continued Thursday amid a series of analyst downgrades after MRTX stock lost about half of its value in three days.

Investors Business Daily

1 No-Brainer Stock to Buy When the Market Plunges

CVS Health (CVS) beat revenue and EPS estimates for the 2022 third quarter. Moreover, the stock has gained more than 10% over the past year despite the market turmoil. Also, it currently pays its shareholders a more than 2% dividend. Therefore, CVS might be an ideal buy amid challenging times.…

StockNews.com

Here's What We Know So Far About Amgen's Obesity Drug As It Trails Novo Nordisk, Eli Lilly

Amgen is years behind rivals in developing an obesity treatment, but the company says its experimental drug could prove superior.

Investors Business Daily

GPs and pharmacies ‘struggling to obtain antibiotics to treat strep A’

Comments from representative bodies as government continues to insist there are no shortages

The Guardian - UK

Read news from The Economist, FT, and more,
with one subscription

Omicron-fighting COVID vaccine authorized for kids as young as 6 months

The omicron-fighting COVID-19 vaccine is now approved for children ages 6 months and older, the U.S. Food and Drug Administration said Thursday.

Tribune News Service

Narcan could be required at California schools after youth fentanyl overdoses

SACRAMENTO, Calif. — Following spates of fentanyl overdoses among students, California public schools could be required to provide Narcan on campuses — a nasal spray that can reverse deadly effects of opioids.

Los Angeles Times

IBD 50 Stocks To Watch: Health Stock Nears Buy Point, Leads Rising Industry

Leading health stock is within 2% of a buy point of a newly formed base. Shares are up over 7% this quarter and approaching its 52-week high.

Investors Business Daily

Tell us: have you noticed a shortage of antibiotics for strep A?

We’d like to hear from pharmacists, GPs, health professionals and parents about any shortage of antibiotics to treat strep A

The Guardian - UK

Pharmacy ownership changes could creep into new legislation

The introduction of the long-awaited Therapeutic Products Bill has excluded changing the rules on pharmacy ownership but Andrew Little told Newsroom he’ll keep an open mind.

Newsroom.co.nz

FDA clears updated COVID-19 vaccines for kids under age 5

U.S. regulators have cleared doses of the updated COVID-19 vaccines to children younger than 5

The Independent UK

French farmer poisoned by Monsanto herbicide wins 'paltry' compensation

After 15 years of legal proceedings, French farmer Paul François, who was accidentally poisoned by a Monsanto herbicide in 2004, will receive compensation - but much less than he had asked for.

Radio France Internationale

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Entrada Skyrockets On $250 Million Deal With Vertex In Muscular Dystrophy

Entrada Therapeutics inked a $250 million deal with Vertex Pharmaceuticals to develop a muscular dystrophy drug, and the biotech stock surged.

Tribune News Service

Employers use patient assistance programs to offset their own costs

Anna Sutton was shocked when she received a letter from her husband’s job-based health plan stating that Humira, an expensive drug used to treat her daughter’s juvenile arthritis, was now on a long list of medications considered “nonessential benefits.”

France 24

'€11,000 for so much sacrifice': Bayer pesticide ruling ends French farmer's 15-year battle

A French court has ordered Germany's Bayer to pay compensation of some 11,000 euros to a crop farmer for the accidental inhalation of a weedkiller produced by its subsidiary Monsanto, ending a 15-year legal battle, his lawyer and the company said on Thursday.

WEKU

The White House unveils a new system to track and better prevent opioid overdoses

The Biden administration will use data from EMS first responders to track overdoses. The focus will be on improving response to a public health crisis that kills more than 100,000 Americans annually.

Get all your
news in one place.

100’s of premium titles.
One news app.

Reuters

French farmer wins $11,700 in Bayer pesticide fumes case

Germany's Bayer has been ordered to pay compensation of 11,135 euros ($11,700) to a French farmer who inhaled fumes from a weedkiller, ending a 15-year legal battle.

Wales Online

Measles declared an imminent global threat by World Health Organization

A record number of nearly 40 million children missed at least one measles vaccine dose in 2021

Daily Record

"It's like watching a child" - Wife of Alzheimer's patient in desperate plea as Brexit set to delay new drug

The drug, Lecanemab, was hailed as a new wonder pill which can slow down Alzheimer’s - but it could take several years for approval in the UK, now we're out of the EU.

AFP

Ramesh 'Sunny' Balwani gets prison time for Theranos fraud

San Francisco (AFP) - A judge on Thursday sentenced a top aide and ex-boyfriend of fallen Theranos founder Elizabeth Holmes to prison for duping people into trusting the failed blood testing startup.

Chicago Sun-Times

Paxlovid free so far, but sticker shock awaits next year if you need the COVID treatment

Within months, the government plans to stop footing the bill — and millions of the uninsured and seniors might have to pay full price. Experts say that means fewer people will get the potentially life-saving treatments.

Tribune News Service

CDC head asks for COVID-19 funding, data as Hill interest fades

WASHINGTON — The Centers for Disease Control and Prevention is running out of ways to be creative with its limited pandemic funds and needs more flexibility from Congress, Director Rochelle Walensky told CQ Roll Call in an exclusive interview Wednesday.

Daily Mirror

Strep A: Pharmacies warn of shortages in antibiotics as 20 ill at single school

It comes as the UK continues to be rocked by a surge in cases of Strep A with several cases of the potentially deadly invasive Strep A being reported among schoolchildren in recent weeks

1 … 68 69 70 71

People

Ramesh ‘Sunny’ Balwani

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

World Health Organization

UK Health Security Agency

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.